Thyroid disease has been paid more and more attention at present. Thyroid enlargement, hyperthyroidism and hypothyroidism are easy to be found due to obvious symptoms, and the rate of seeking medical advice is high. But for some asymptomatic thyroiditis, it is usually easy to be missed, misdiagnosed or over treated.
The US FDA has approved pemigatinib, the first targeted drug to date for patients with specific mutated blood tumours, and the results of the study show that the drug made tumours disappear completely in 79% of patients!
